© Versita Sp. z o.o. Cis-diamminedichloroplatinum(II) (cisplatin) was immobilized in a star-shaped polymer carrier. In order to define whether this polymer could be used as a drug delivery system for cisplatin, its characteristics, e.g. loading efficiency and release profile of cisplatin from the polymer in phosphate buffered saline (PBS), have to be assessed, and hence an appropriate analytical procedure for precise and reliable determination of Pt(II) must be established. Optimal instrumental parameters for Pt measurement by commonly used atomic spectrometric methods ETAAS and ICP-OES in various examined media were defined. Matrix interferences observed that were related to both techniques were evaluated, and analytical figures of merit were compared and critically discussed.
Introduction
Platinum-based drugs represent a large part of all existing antineoplastic agents. The most common one among them is Cis-diamminedichloroplatinum(II) ([PtCl 2 (NH 3 ) 2 ], cisplatin), usually administered intravenously for the treatment of solid tumours. Despite its continuous use, chemotherapy with cisplatin presents several disadvantages including severe toxicity and a short circulation period in the blood due to its fast glomerular excretion [1] . A prospective strategy for reducing side effects of antineoplastic agents while retaining their potency is their immobilization in a polymer carrier [2, 3] . In the present study, a core-shell type star-shaped macromolecule bearing carboxylate groups is studied as a drug delivery system for cisplatin. It consists of a hyperbranched polystyrene core and arms made up from polyacrylic acid and is assigned as PSPA. Additionally, the PEGylation of PSPA helped improve performance of the therapeutic system (PEGPSPA). PEG (polyethylene glycol) chains increase the hydrodynamic size of the particle and hinder protein interactions [4] , protecting it from enzymatic degradation through recognition by cells of the immune system and fast renal clearance. Determination of loading efficiency of PSPA/PEGPSPA and Pt release profile from the polymer chains requires reliable and accurate Pt determination in various media. In recent years, the technique of inductively coupled plasma optical emission spectrometry (ICP-OES) has been increasingly used for quantitative determination of many metals, including Pt. The method is sensitive enough for direct determination of Pt in blood [18, 8] and urine [19] of patients treated with platinum-based anticancer drugs. Typically, ICP-OES measurements are characterized with less than 1% RSD in a wide linear response range, covering five to seven orders of magnitude in concentration [20] . Matrix effects encountered while performing ICP-OES measurements may be divided into two basic categories: matrix induced spectral overlap problems (additive) and matrix induced signal intensity changes (multiplicative) [21] [22] [23] .
The aim of this study is to develop a reliable analytical approach for Pt determination and its application for characterization of the loading efficiency and further the release profile of the drug from the newly synthesized macromolecular carriers (PSPA and PEGPSPA). The possibilities of both atomic spectrometric methods, ETAAS and ICP-OES, will be studied for quantification of Pt, conjugated to a polyacrylate matrix and polyacrylate matrix bearing PEG chains as well as for Pt quantification in the presence of buffer media (phosphate buffer saline, PBS). Application of ETAAS or ICP-OES will be compared and discussed from the viewpoint of lower matrix interferences and longer linear working range. Analytical figures of merit achieved by both techniques under optimal instrumental parameters will be presented.
Experimental procedure

Instrumentation
The ETAAS-measurements were carried out on a Perkin-Elmer (Norwalk, CT, USA) Zeeman 3030 spectrometer with an HGA-600 graphite furnace. Light source used was hollow cathode lamp for Pt (PerkinElmer). Pyrolytic graphite coated graphite tubes were used as atomizers. Micropipettes (Eppendorf, Westbury, NY, USA) were used for manual injections of sample solution (20 µL) into the graphite atomizers. Peak area of absorbance signal was used for quantification. Instrumental parameters are given in Supplementary Table 1 .
The ICP-OES-measurements were carried out on a ULTIMA 2, Jobin Yvon spectrometer. Instrumental parameters are given in Supplementary Table 2.
Materials, reagents and methods
Synthetic routes towards PSPA were described in earlier studies [24, 25] . A hyperbranched product was obtained using self-condensing polymerization of p-(iodomethyl) styrene. It contained one double bond [26, 27] , on average up to 10 active iodomethyl or iodomethine groups [28] and was used as a multifunctional initiator of the living polymerization of tert-butyl acrylate. Star shaped macromolecules with arms bearing active ester functionalities were obtained. GPC-MALLS measurement of the copolymer displayed the following characteristics: monomodal distribution of molar masses, M n =56 800 g mol -1 and M w /M n =1.84. Further, the acid hydrolysis of the active ester groups of the precursor star copolymer yielded macromolecular structures with a branched hydrophobic interior and hydrophilic shell from poly(acrylic acid) chains. The mean R h value of the PSPA particles measured by DOSY was 11.4 nm.
Synthesis of a star copolymer with a releasable PEG shell (PEGPSPA) is described in [29] . Preparation of the PEGylating agent involved a couple of synthetic steps. The first was the synthesis of methoxyPEG 2000 succinate from poly(ethylene glycol) monomethylether with a molar mass 2000 g mol -1 and succinic anhydride. The next step was the complexing of the PEG chains bearing a chelating carboxylate moiety at the polymer terminus with a drug molecule. The unbound cisplatin was removed from the product through dissolving of the PEG-drug conjugate in acetone and filtering off the undissolved solid.
Platinum standard for AAS TraceCert ® , Fluka Analytical (1001 mg L -1 ) was used for the preparation of working standard solutions.
Cis-Dichlorodiamminoplatinum(II) (cisplatin) (99.9%) was purchased from Sigma-Aldrich. Dialysis membranes with MWCO 3500 and 12000-14000 were supplied by SpectraPor.
Phosphate buffered saline (pH 7.4) was prepared by dissolving NaH 2 PO 4 (0.468 g), Na 2 HPO 4 (2.07 g) and NaCl (12.27 g) in distilled water (1.5 L).
Procedures for sample preparation
Loading of PSPA and PEGPSPA with cisplatin
Loading of PSPA was described in detail in [25] . In summary, cisplatin was added to an aqueous solution of PSPA and PEGPSPA at pH 9.0 at a molar ratio of cisplatin to carboxylate groups 1:3, followed by stirring of the mixture for 24 h (48 h when loading PEGPSPA) at room temperature. Unbound cisplatin was removed by dialysis against deionized water for 48 h using a membrane with MWCO 3500 for PSPA and with MWCO 12000-14000 for PEGPSPA. A second loading of the PEGylated carrier was performed in a similar manner using a greater amount of cisplatin (i.e., molar ratio cisplatin to carboxylate groups was 1:2.5). Loading efficiency of both PSPA and PEGPSPA was defined by Pt determination in polymer conjugates after dialysis. Loaded polymers were assigned as PSPA-Pt and PEGPSPA-Pt, respectively.
Platinum (II) complexes release from PSPA-Pt and PEGPSPA-Pt
Release of Pt(II) complexes from the polymer carrier in PBS was studied by dialysis method using a membrane with MWCO 3500. A PSPA-Pt solution of known platinum drug concentration was placed into a dialysis bag and dialyzed against PBS at 37ºC and gentle stirring. Aliquots were taken from the solution outside of the bag at defined time periods and fresh PBS solution of the same volume was added. Concentration of Pt in the dialyzate aliquots was measured and represents Pt(II) release rate from PSPA. The release rate of Pt(II) complexes from the loaded PEGPSPA was evaluated under the same experimental conditions using a membrane with MWCO 12000-14000.
Results and discussion
Reliable characterization and assessment of both PSPA and PEGPSPA as efficient cisplatin delivery systems requires accurate and precise measurement of Pt content in two different sample media: relatively high Pt concentrations in the presence of polymeric matrix built up from polyacrylic acid/polyacrylic acid bearing PEG chains and relatively low Pt concentrations in the presence of PBS (as described in Chapter 2.3.).
Analytical procedure based on ETAAS
Evaluation of the cisplatin release profile from polymeric molecules requires Pt measurement at very low concentration levels in difficult sample solutions -PBS solution. Both constituents of this buffer, phosphate and NaCl are well known interferents for Pt determination by ETAAS. Pyrolysis and atomization curves for model solutions containing known amounts of Pt standards in the presence of PBS were prepared in order to define optimal instrumental parameters. Pyrolysis temperature was varied ranging from 1000ºC (considering the presence of NaCl and formation of volatile Pt chlorides) to 1500ºC. Experiments performed showed that loss free pyrolysis temperature of 1300ºC ( Fig. 1 ) could be achieved, however even a hold time of 60s at this temperature could not completely eliminate strong and irreproducible background absorption signals observed, evidently due to NaCl present in PBS. The only possibility is injection of smaller sample volumes or at least doubling the PBS sample dilution with doubly distilled water. Pyrolysis and atomization curves presented in Fig. 1 also showed strong signal depression for undiluted samples. Nearly the highest possible atomization temperature of 2650ºC should be used for complete Pt atomization in PBS solution.
Matrix interferences due to PBS matrix were evaluated through the ratio of the slopes of calibration curves obtained in the presence of PBS solution (b s ) and for aqueous standard solutions (b aq ). Taking into account results presented in Table 1 , the calibration procedure based on matrix (PBS) matched standards is recommended for accurate and precise ETAAS quantification of Pt in PBS solutions diluted 1:1 with doubly distilled water. 
Analytical procedure based on ICP-OES
Loading efficiency assessment of both PSPA-Pt and PEGPSPA-Pt requires measurement of Pt in the presence of polymer matrix. Model solutions containing known amounts of Pt and polymer matrices at ratios 1:3 and 1:2 respectively, were prepared and measured by ICP-OES under optimal instrumental parameters by using three Pt wavelengths: 203.646 nm, 214.423 nm and 265.945 nm. Results obtained for the ratio of the slopes of calibration graphs in the presence of polymer matrix (b s ) and for aqueous standards (b aq ) undoubtedly showed absence of any spectral and matrix interferences. The presence of undigested organic polymer does not significantly increase plasma background emission. Simple calibration against aqueous standard calibration graph is recommended for Pt quantification. As far as relatively high Pt concentrations have to be measured, the spectral line at 265.945 nm is proposed as most suitable, ensuring a long linear working range of almost 1000 mg L -1 Pt in sample solution. Determination of Pt at low concentration levels in PBS is a more difficult task. As spectral method ICP-OES is typically characterized with low sensitivity toward non-spectral (chemical) interferences, it might be expected that the large amounts of Na-salts can cause serious spectral and ionization interferences. In order to ensure reliable ICP-OES measurements, sample uptake and nebulization flow rates as well as integration time were carefully optimized at both wavelengths 203.646 nm and 214.423 nm, which are characterized with highest sensitivity toward Pt. It might be expected that relatively narrow entrance slits and lower integration times are preferable in this case ensuring higher signal to noise ratio. However, this also means higher detection limits. Experiments were performed with model PBS solutions previously spiked with known Pt concentrations in the lowest concentration range of 0.02-0.05 mg L -1 for optimization of sample uptake, entrance slit, integration time and sheath gas flow rate. Results obtained for optimal instrumental parameters defined on the basis of maximum achieved signal to noise ratio for Pt measurement are presented in Supplementary Table 2 . It should be mentioned that even under optimal instrumental parameters, careful assessment and correction of plasma emission, e.g. background emission control on the both sides of Pt spectral lines (203.646 nm and 214.423 nm), should be included in the analytical method. In order to avoid additional use of ionization buffers or Cs salts (to overcome ionization interferences) which will increase total dissolved solids, calibration against a calibration curve prepared with matrix-matched standards based on PBS buffer is recommended. As far as certified reference materials are not available, the accuracy of both recommended procedures for Pt determination in PBS, e.g. by using ETAAS or ICP-OES, was approved by analysis of parallel samples under defined optimal instrumental parameters. As can be seen from results presented in Table 2 , the very good agreement achieved confirms validity and versatility of analytical methods developed for Pt determination in PBS.
Comparison of analytical figures of merit is presented in Table 3 . The limits of detection and quantification for platinum determination in PBS by both studied methods (ETAAS and ICP OES) were calculated from 10 replicate measurements of the model PBS solution spiked with 0.05 mg L -1 Pt on the basis of 3σ-and 10 σ-criteria, respectively. This approach is a more realistic way to characterize detection capabilities of analytical methods developed for Pt determination in PBS samples.
Analytical application
The developed analytical procedures allowed determination of two key characteristics of the delivery systems, which were the loading efficiency and the release profile. Loading efficiency is defined as the amount of the loaded drug against the one added to the reaction mixture. In the case of our systems, loading of the polymer with cisplatin proceeds via a ligand exchange reaction -a chloride ligand from the cisplatin molecules is exchanged for a carboxylate ligand from the polyacrylic arms of the stars. Every cisplatin molecule bears two chloride ligands and hence a single cisplatin molecule can bind to a maximum of two carboxylic groups. Taking the above into consideration, loading experiments were done at 3-fold or 2.5-fold molar excess of the acrylate units toward drug feed concentration. Pt determination of PSPA-Pt and PEGPSPA-Pt showed high loading efficiency for both carriers: 82% for PSPA and 79% for PEGPSPA. The desired result was macromolecular carriers that efficiently conjugated cisplatin and also bearing a certain quantity of the carboxylate anions to remain uncomplexed thus affording hydrophilicity and a net negative charge of the loaded particles to provide solution stability against precipitation. The percentage of Pt(II) released from PEGPSPA is about 40%, significantly higher than this for PSPA (about 30%). It is worth mentioning that the observed sustained release of Pt(II) complexes from PSPA-Pt and PEGPSPA-Pt without initial burst effect has a great advantage for the passive drug targeting to solid tumors because of the prolonged time periods known to be required for macromolecular drugs to accumulate in solid tumors through the bloodstream [30] .
Conclusion
Both atomic spectrometric methods, ETAAS and ICP-OES, are appropriate for characterization of investigated new polymeric delivery system (PSPA, PEGPSPA) for cisplatin. Accurate and precise results could be obtained after careful optimization of instrumental parameters. Calibration against matrix-matched standards is recommended in both cases. Analytical methods developed based on ICP-OES measurements are more suitable for routine laboratory practice taking into account lower detection limits achieved in PBS and longer linear working range. 
